USA Financial Formulas’s Vericel Corp VCEL Stock Holding History

USA Financial Formulas’s Portfolio VCEL Stock Details VCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,650	Closed	-$203K	–	449
2021 Q1	$203K	Buy	+3,650	New	+$165K	0.16%	119

Other funds holding VCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

USA Financial Formulas's VCEL Position: Q2 2021 in Review

USA Financial Formulas sold out of Vericel Corp (VCEL) in Q2 2021, closing a stake of 3,650 shares — an estimated $203K sold.

USA Financial Formulas first reported a position in VCEL in Q1 2021 and held it in 1 quarter. The position peaked at $203K in Q1 2021. 205 funds tracked by Wall St. Rank hold VCEL as of Q2 2021.

USA Financial Formulas reported no remaining Vericel Corp position as of Q2 2021 after selling out during the quarter.
USA Financial Formulas sold 3,650 Vericel Corp shares in Q2 2021, an estimated $203K.
USA Financial Formulas first reported a position in Vericel Corp in Q1 2021 and held it in 1 quarter.
USA Financial Formulas's Vericel Corp position peaked at $203K in Q1 2021.
205 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2021.

Based on USA Financial Formulas's 13F filing for Q2 2021, filed 29 Jul 2021.